Eyedaptic Augmented Reality Visual Aid Granted Patent to Further Aid Those With Macular Degeneration and Low Vision
Summary
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Eyedaptic, Inc., a natural vision software company, announced today they were recently granted their first out of nine pending patents. Additionally, Eyedaptic launched an Equity Crowdfunding Campaign to increase awareness and introduce their advanced visual aid solution to an expanding list of stakeholders in the eye care and technology communities. Conditions such as age-related macular degeneration (AMD) and retinal disorders are steadily on the rise and impact over 170 million people worldwide, signifying the need for a reliable, cost-effective and mobile-friendly solution. The company is off to a strong start with a wide variety of investors including current Eyedaptic users, vision care specialists and ophthalmologists who are passionate to increase awareness and generate additional momentum through an early adopter program and expanding its network of supporters. Eyedaptic is a privately held company that develops visual aid software, enabled by augmented reality hardware, for macular degeneration and other retinal diseases.